NO20080104L - Inhibitorer av loselig adenylatsyklase - Google Patents

Inhibitorer av loselig adenylatsyklase

Info

Publication number
NO20080104L
NO20080104L NO20080104A NO20080104A NO20080104L NO 20080104 L NO20080104 L NO 20080104L NO 20080104 A NO20080104 A NO 20080104A NO 20080104 A NO20080104 A NO 20080104A NO 20080104 L NO20080104 L NO 20080104L
Authority
NO
Norway
Prior art keywords
adenylate cyclase
cyclase inhibitors
soluble adenylate
soluble
inhibitors
Prior art date
Application number
NO20080104A
Other languages
English (en)
Inventor
Bernd Buchmann
Bernd Menzenbach
Duy Nguyen
Martin Fritsch
Ulf Boemer
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Publication of NO20080104L publication Critical patent/NO20080104L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D333/70—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Furan Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

Oppfinnelsen vedrører forbindelser med generell Formel (I), fremstillingen derav og anvendelsen av derav som et medisinsk produkt.
NO20080104A 2005-06-08 2008-01-07 Inhibitorer av loselig adenylatsyklase NO20080104L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102005027274A DE102005027274A1 (de) 2005-06-08 2005-06-08 Inhibitoren der löslichen Adenylatzyklase
PCT/EP2006/005608 WO2006131398A2 (en) 2005-06-08 2006-06-07 Inhibitors of soluble adenylate cyclase

Publications (1)

Publication Number Publication Date
NO20080104L true NO20080104L (no) 2008-03-03

Family

ID=37398540

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20080104A NO20080104L (no) 2005-06-08 2008-01-07 Inhibitorer av loselig adenylatsyklase

Country Status (23)

Country Link
EP (1) EP1888058B1 (no)
JP (1) JP2008542422A (no)
KR (1) KR20080016617A (no)
CN (1) CN101193631A (no)
AR (1) AR054378A1 (no)
AT (1) ATE431736T1 (no)
AU (1) AU2006256857A1 (no)
BR (1) BRPI0610934A2 (no)
CA (1) CA2606692A1 (no)
CR (1) CR9578A (no)
DE (2) DE102005027274A1 (no)
DO (1) DOP2006000130A (no)
EA (1) EA200702590A1 (no)
EC (1) ECSP078024A (no)
GT (1) GT200600244A (no)
IL (1) IL186914A0 (no)
MX (1) MX2007015493A (no)
NO (1) NO20080104L (no)
PE (1) PE20061488A1 (no)
TW (1) TW200716090A (no)
UY (1) UY29583A1 (no)
WO (1) WO2006131398A2 (no)
ZA (1) ZA200800153B (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102006014319B4 (de) * 2006-03-23 2009-01-08 Bayer Schering Pharma Aktiengesellschaft Inhibitoren der löslichen Adenylatzyklase
EP2036906A1 (de) * 2007-09-05 2009-03-18 Bayer Schering Pharma Aktiengesellschaft Azaindole als Inhibitoren der löslichen Adenylatzyklase

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2635776B1 (fr) * 1988-09-01 1993-06-11 Rhone Poulenc Agrochimie Derives amides, procede pour leur fabrication et compositions fongicides les contenant
US20020064849A1 (en) * 2000-09-05 2002-05-30 Herr John C. Human soluble testicular adenylyl cyclase
OA12626A (en) * 2001-06-28 2006-06-13 Pfizer Prod Inc triamide-substituted indoles, benzofuranes and benzothiophenes as inhibitors of microsomal triglyceride transfer protein (MTP)and/or apolipoprotein B(APO B) secretion.
CN1578663B (zh) * 2001-09-14 2011-05-25 梅特希尔基因公司 组蛋白脱乙酰化酶抑制剂
UA79504C2 (en) * 2002-11-07 2007-06-25 Organon Nv Indols for treating diseases associated with androgen receptors
EP1663242B1 (en) * 2003-08-07 2011-04-27 Rigel Pharmaceuticals, Inc. 2,4-pyrimidinediamine compounds and uses as anti-proliferative agents
CA2542096A1 (en) * 2003-10-09 2005-04-21 Aton Pharma, Inc. Thiophene and benzothiophene hydroxamic acid derivatives
EP1706114B1 (en) * 2004-01-21 2012-12-26 Cornell Research Foundation, Inc. Chemical inhibitors of soluble adenylyl cyclase (sac)
AU2005225471B2 (en) * 2004-03-26 2011-05-12 Methylgene Inc. Inhibitors of histone deacetylase
DE102004047272A1 (de) * 2004-09-24 2006-04-06 Schering Ag Inhibitoren der löslichen Adenylatzyklase

Also Published As

Publication number Publication date
IL186914A0 (en) 2008-02-09
ATE431736T1 (de) 2009-06-15
BRPI0610934A2 (pt) 2010-08-03
DOP2006000130A (es) 2006-11-30
GT200600244A (es) 2007-01-23
EP1888058B1 (en) 2009-05-20
ZA200800153B (en) 2009-03-25
AU2006256857A1 (en) 2006-12-14
CA2606692A1 (en) 2006-12-14
PE20061488A1 (es) 2007-02-03
WO2006131398A3 (en) 2007-04-19
EA200702590A1 (ru) 2008-06-30
AR054378A1 (es) 2007-06-20
ECSP078024A (es) 2008-01-23
DE102005027274A1 (de) 2006-12-14
UY29583A1 (es) 2007-01-31
JP2008542422A (ja) 2008-11-27
EP1888058A2 (en) 2008-02-20
TW200716090A (en) 2007-05-01
WO2006131398A2 (en) 2006-12-14
CN101193631A (zh) 2008-06-04
DE602006006908D1 (de) 2009-07-02
KR20080016617A (ko) 2008-02-21
MX2007015493A (es) 2008-02-22
CR9578A (es) 2008-03-06

Similar Documents

Publication Publication Date Title
NO20070224L (no) 2-karbamid-4-fenyltiazolderivater, fremstilling og terapeutisk anvendelse derav
NO20090295L (no) Substituerte heteroarylderivater
NO20090628L (no) Pyridizinon derivativater
MY149512A (en) Pyrazolylaminopyridine derivatives useful as kinase inhibitors
WO2005075425A3 (en) Substituted bisarylurea derivatives as kinase inhibitors
EA200870193A1 (ru) Цитотоксические агенты, включающие новые производные томаймицина, и их терапевтическое применение
NO20071074L (no) Substituerte cykliske ureaderivater, fremstilling derav og farmasoytisk anvendelse derav som kinaseinhibitorer
WO2006123113A3 (en) Pyrazolylaminopyrimidine derivatives useful as tyrosine kinase inhibitors
DK1853602T3 (da) Kemiske forbindelser
DK1853588T3 (da) Kemiske forbindelser
NO20065946L (no) DPP-IV-inhibitorer
GEP20084452B (en) Sulfonamide derivatives for the treatment of diseases
PL1899329T3 (pl) Pirymidyno-podstawione pochodne benzimidazolu jako inhibitory kinaz białkowych
NO20070089L (no) DPP-IV inhibitorer
EA200900135A1 (ru) Производные пиразола в качестве ингибиторов цитохрома р450
NO20083708L (no) 4-Fenyl-tiazol-5-karboksylsyre og 4-fenyl-tiazol-5-karboksylmider som PLK1-inhibitorer
WO2007009724A3 (en) Cycloalkane-substituted pyrazoline derivatives, their preparation and use as medicaments
NO20073631L (no) Metasubstituerte tiazolidinoner, fremgangsmate for fremstilling og anvendelse av disse som legemiddel
EA201001747A1 (ru) Бензоксазиноновые производные, действующие в качестве агониста бета-2-адренорецептора, для лечения респираторных расстройств
MY150098A (en) Benzylpiperazine derivates and their medical use
NO20072078L (no) Indolderivater som inhibitorer av loselig adenylsyklase
UA106200C2 (uk) Заміщені похідні оксіндолу та їхнє застосування для лікування захворювань, залежних від вазопресину
IL191670A0 (en) Compounds for the inhibition of apoptosis
NO20080104L (no) Inhibitorer av loselig adenylatsyklase
NO20083352L (no) 2-karbamid-4-fenyltiazolderivater, fremstilling og terapeutisk anvendelse derav

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application